Location: Home
  • search
  • go
  • Relate News
  • 11/4/2025Everest Acquires Exclusive Greater China and Other Asian Country Right...
  • 11/4/2025NovaBridge Biosciences (I-Mab) Files for Hong Kong IPO
  • 11/4/2025Huadong Medicine Initiates Phase I Trial of CDH17-Targeting ADC HDM201...
  • 11/4/2025Lepu Licenses GLP-1/GIP/FGF21 Agonist MWN105 to Sidera in US$1.05B Dea...
  • 11/4/2025NHSA Introduces New Measure to Strengthen Intelligent Oversight of Exc...
  • 11/4/2025China's BMI Fund Maintains Strong Surplus in First Three Quarters of 2...
  • 10/31/2025NMPA Grants Conditional Approval for Lepu Biotech's Becotatug Vedotin
  • 10/31/2025Asia Regenerative Medicine Completes Series A Funding
  • 10/31/2025Bayer to Divest Avelox Assets to HSG in Deal Valued up to €260 Millio...
  • 10/31/2025Sichuan Biokin Advances 11th ADC Candidate BL-M24D1 into Clinical Tria...
  • 10/31/2025Junshi's Toripalimab Becomes First Immunotherapy Approved for NPC in C...
  • 10/31/2025Lumosa's Stroke Drug Achieves Phase IIb Success in China
  • 10/31/2025China Adds Novel Drugs Catalog to National BMI Talks for the First Tim...
  • 10/31/2025China Overhauls Drug Procurement and Reimbursement Framework to Balanc...
  • 10/29/2025Abbisko Presents Promising Preclinical Data on Novel CDK4/2 Inhibitor ...
  • 10/29/2025NMPA Approves Huadong Pharma's Mifanertinib Maleate for EGFR-Mutant NS...
  • 10/29/2025Immunofoco Raises Series B+ Funding to Advance CAR-T Platforms for Sol...
  • 10/29/2025Pharmaron to Acquire Biortus in China
  • 10/29/2025NHSA Launches Public Consultation Module for DRG Payment Grouping Plan...
  • 10/29/2025China Issues Guidelines to Strengthen Primary Care Chronic Disease Man...
  • 10/28/2025Innovent's Mazdutide Tops Ozempic in Phase III Diabetes and Obesity Tr...
  • 10/28/2025Metis TechBio to File China NDA for AI-Designed PBA Drug MTS-004
  • 10/28/2025Over 400 Companies Join China's 11th Round of VBP
  • 10/27/2025Lanma's LM103 TIL Therapy Moves Into Phase 2 After Promising Phase 1 D...
  • 10/27/2025Alphamab Doses First Patient in Phase 1 Trial of PD-L1/αvβ6 Bispecif...
  • 10/27/2025Zai Lab Shares Phase 1 Data for DLL3-Targeted ADC Rivaling Amgen's Imd...
  • 10/27/2025AstraZeneca Unveils Three Major Initiatives in China
  • 10/25/2025Recent Executive Moves
  • 10/24/2025Boehringer Ingelheim's Jascayd Wins NMPA Approval for IPF
  • 10/24/2025METiS's AI-Designed MTS-004 Becomes China's First AI-Enabled Formulati...
  • Page:1/370 Total number of articles:11093: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group